Komori
Zacros (7917) · InitiativeAdvanced

Strengthening Sales of High-Value-Added Products and Improving Production Efficiency

First written in FY2016. 17 of 24 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.

24entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019-Q1 – FY20262016: 320162017: 420172018: 420182019: 320192020: 420202021: 320212022: 220222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Profit Improvement through High-Value-Added Product Sales and Production Efficiency ImprovementsA theme 60 companies write about · 1 as a headwind · 62 as a tailwind

30 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 60 companies compared. The sentences above are computed from all 60.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In addition to the benefits of higher revenue in the Information Electronics and Industrial Infrastructure businesses, operating profit and ordinary profit increased year on year as a result of efforts to improve profitability, including higher production efficiency and price pass-through.」

    Operating profit increased 9.3% year on year, driven by profitability improvement measures including the shift toward higher value-added products, improved production efficiency and price pass-through.
  2. FY2022AdvancedAnnual report

    「Sales of pharmaceutical and medical packaging materials by overseas subsidiaries were substantially higher than in the same period of the previous year. In addition, sales of single-use bags for biopharmaceutical and other manufacturing applications and related products remained strong, resulting in higher revenue for the business as a whole.」

    Strong sales of pharmaceutical and medical packaging materials and single-use bags by overseas subsidiaries drove 17.9% year-on-year revenue growth in the wellness business.
  3. FY2022-Q3AdvancedAnnual report

    「Sales of packaging materials for household products increased as sales of large-capacity, multi-use refill pouches continued to grow steadily. Sales of liquid containers also increased, supported by strong sales at overseas subsidiaries.」

    Sales of large-capacity, multi-use refill pouches and liquid containers by overseas subsidiaries contributed to higher revenue.
  4. FY2022-Q1AdvancedAnnual report

    「In pharmaceutical and medical packaging materials, sales of single-use bags for biopharmaceutical manufacturing and related products were substantially higher than in the previous year. In packaging materials for household products, sales of large-capacity, multi-use refill pouches also continued to grow steadily, resulting in higher revenue.」

    Sales of single-use bags for biopharmaceutical manufacturing and other products, as well as large-capacity, multi-use refill pouches, increased. However, lower revenue from food packaging materials and liquid containers resulted in lower revenue for the business as a whole.
  5. FY2021AdvancedAnnual report

    「Sales of packaging materials for household products increased, as sales of large-capacity, multi-use refill pouches continued to grow steadily. In food packaging materials, orders declined, mainly for packaging materials for the food-service industry, but sales exceeded the previous year due to sales of filling and conveying systems and other products. Meanwhile, in pharmaceutical and medical packaging materials, sales of single-use bags for biopharmaceutical manufacturing and related products increased, but orders declined, mainly for pharmaceutical release films, due to the impact of patients avoiding hospital visits because of COVID-19, resulting in lower revenue.」

    Large-capacity refill pouches, filling and conveying systems, single-use bags for biopharmaceutical manufacturing and other high-value-added products demonstrated tangible results from efforts to strengthen sales. Revenue for the life sciences business as a whole was ¥56,376 million, down 0.3% year on year.
  6. FY2021-Q3AdvancedAnnual report

    「In terms of profit and loss, depreciation expenses increased due to the operation of newly installed machinery at the Company's Showa Plant, while strategic spending and fixed costs, mainly personnel expenses associated with higher production volumes, also increased. However, higher revenue, stronger sales of high-value-added products, improved production efficiency across the Group and efforts to improve the performance of overseas subsidiaries resulted in higher profit than in the same period of the previous year.」

    Although fixed costs and other expenses increased, stronger sales of high-value-added products and improved production efficiency contributed to higher profit.
  7. FY2021-Q2AdvancedAnnual report

    「In food packaging materials, orders declined, mainly for packaging materials for the food-service industry, but sales exceeded the previous year due to sales of filling and conveying systems. In packaging materials for household products, sales to the cosmetics industry declined, but higher sales of large-capacity, multi-use refill pouches resulted in higher revenue. In pharmaceutical and medical packaging materials, orders for pharmaceutical release films declined, but sales increased, led by single-use bags for biopharmaceutical manufacturing and related products, resulting in higher revenue for the business as a whole. As a result, revenue was ¥28,684 million, up 0.2% year on year.」

    Amid declines in some areas, including food-service applications, sales of large-capacity refill pouches, filling and conveying systems, single-use bags for biopharmaceutical manufacturing and other products contributed to 0.2% year-on-year revenue growth in the life sciences business.
  8. FY2021-Q1AdvancedAnnual report

    「Sales of liquid containers remained firm as demand increased for disinfectants and sanitising agents. Sales of pharmaceutical and medical packaging materials also grew, led by single-use bags for biopharmaceutical manufacturing and related products, resulting in higher revenue for the business as a whole. As a result, revenue was ¥14,604 million, up 4.9% year on year.」

    The life sciences business reported 4.9% year-on-year revenue growth, driven by liquid containers for disinfectants and sanitising agents, single-use bags for biopharmaceutical manufacturing and other products.
  9. FY2020AdvancedAnnual report

    「Expanded sales of large-capacity, multi-use refill bags in packaging materials for household products made a significant contribution. In addition, sales of pharmaceutical and medical packaging materials increased, particularly for single-use bags and related products used in biopharmaceutical manufacturing, while sales of liquid containers, food packaging materials, and other products also grew. As a result, sales increased for the business as a whole. Net sales were ¥56,534 million, up 3.3% year on year.」

    The life sciences business reported full-year revenue growth of 3.3% year on year, driven by increased sales of large-capacity refill pouches, single-use bags for biopharmaceutical manufacturing and other products.
  10. FY2020-Q3AdvancedAnnual report

    「Expanded sales of large-capacity, multi-use refill bags in packaging materials for household products made a significant contribution. In addition, sales of pharmaceutical and medical packaging materials increased, particularly for single-use bags and related products used in biopharmaceutical manufacturing, while sales of liquid containers, food packaging materials, and other products also grew. As a result, sales increased for the business as a whole.」

    Expanded sales of large-capacity refill bags, single-use bags and related products for biopharmaceutical manufacturing, liquid containers, and food packaging materials resulted in Life Sciences sales up 4.1% year on year.
  11. FY2020-Q2AdvancedAnnual report

    「Expanded sales of large-capacity, multi-use refill bags in packaging materials for household products made a significant contribution. In addition, sales of pharmaceutical and medical packaging materials increased, particularly for single-use bags and related products used in biopharmaceutical manufacturing, while sales of food packaging materials, liquid containers, and other products also grew. As a result, sales increased for the business as a whole. Net sales were ¥28,614 million, up 5.9% year on year.」

    Expanded sales of large-capacity refill bags, single-use bags and related products for biopharmaceutical manufacturing, food packaging materials, and liquid containers resulted in Life Sciences sales up 5.9% year on year.
  12. FY2020-Q1AdvancedAnnual report

    「Expanded sales of large-capacity, multi-use refill bags in packaging materials for household products made a significant contribution. In addition, sales of pharmaceutical and medical packaging materials for the cell-culture field increased, sales of liquid containers grew, particularly at the U.S. subsidiary, and sales of food packaging materials exceeded the previous year. As a result, sales increased for the business as a whole. Net sales were ¥13,916 million, up 4.0% year on year.」

    Expanded sales of large-capacity refill bags, packaging materials for the cell-culture field, liquid containers, and food packaging materials resulted in Life Sciences sales up 4.0% year on year.
  13. FY2019AdvancedAnnual report

    「Expanded sales of large-capacity, multi-use refill bags in packaging materials for household products contributed, while sales of pharmaceutical and medical packaging materials, liquid containers, and other products were also actively expanded. As a result, sales increased for the business as a whole. Net sales were ¥54,754 million, up 3.4% year on year.」

    Expanded sales of large-capacity refill bags, pharmaceutical and medical packaging materials, liquid containers, and other products resulted in Life Sciences sales up 3.4% year on year.
  14. FY2019-Q2AdvancedAnnual report

    「Sales of food packaging materials, liquid containers, and packaging materials for household products declined. However, sales of pharmaceutical and medical packaging materials increased, particularly for applications in the cell-culture field, and sales of other products were also actively expanded, resulting in higher sales for the business as a whole. As a result, net sales were ¥27,008 million, up 1.5% year on year.」

    While sales of food packaging materials, liquid containers, and packaging for household products declined, pharmaceutical and medical packaging materials for the cell-culture field and other product sales increased, resulting in Life Sciences sales up 1.5% year on year.
  15. FY2019-Q1AdvancedAnnual report

    「Sales of food packaging materials, liquid containers, and packaging materials for household products declined. However, sales of pharmaceutical and medical packaging materials increased, and the company actively expanded sales of other products, resulting in higher sales for the business as a whole. As a result, net sales were ¥13,382 million, up 2.2% year on year.」

    While sales of food packaging materials, liquid containers, and packaging for household products declined, higher sales of pharmaceutical and medical packaging materials and other products resulted in Life Sciences sales up 2.2% year on year.
  16. FY2018RestatedAnnual report

    「Expanded sales of large-capacity, multi-use refill bags in packaging materials for household products, together with sales of food packaging materials exceeding the previous year, resulted in a significant increase in sales for the business as a whole.」

    The company reaffirmed its focus on strengthening sales in the Life Sciences business through expanded sales of refill bags and food packaging materials.
  17. FY2018-Q3RestatedAnnual report

    「Sales of food packaging materials exceeded the previous year, while expanded sales of large-capacity, multi-use refill bags in packaging materials for household products, including packaging for cosmetics and toiletries and refill pouches, also contributed. As a result, the business as a whole posted a significant increase in sales.」

    The company continued to cite stronger packaging-materials sales, including expanded sales of large-capacity, multi-use refill bags, and the resulting increase in revenue.
  18. FY2018-Q2AdvancedAnnual report

    「Sales of packaging materials for household products, including packaging for cosmetics and toiletries and refill pouches, increased as expanded sales of large-capacity, multi-use refill bags contributed. Sales of food packaging materials and liquid containers also exceeded the previous year, resulting in a significant increase in sales for the business as a whole.」

    Expanded sales of large-capacity, multi-use refill bags contributed to sales growth, while food packaging materials and liquid containers also posted sales above the previous year.
  19. FY2018-Q1RestatedAnnual report

    「Sales of packaging materials for household products, including packaging for cosmetics and toiletries and refill pouches, increased as the company continued to expand sales and steadily capture demand,」

    The company reaffirmed the expansion of sales of packaging materials for household products and the resulting sales growth.
  20. FY2017RestatedAnnual report

    「Although the company worked to improve production efficiency, strengthen sales of high-value-added products, and reduce costs,」

    The company continued to cite improved production efficiency, stronger sales of high-value-added products, and cost reductions as measures to improve profitability.
  21. FY2017-Q3RestatedAnnual report

    「In household packaging materials, expanded sales of stand-up refill pouches contributed to higher sales, resulting in increased sales for the business as a whole.」

    The company continued to cite expanded sales of stand-up refill pouches and their contribution to higher sales.
  22. FY2017-Q2AdvancedAnnual report

    「In household packaging materials, sales increased through expanded sales of stand-up refill pouches, while sales of products sold by domestic consolidated subsidiaries also increased. As a result, the business as a whole maintained sales at approximately the same level as in the previous year.」

    As progress in strengthening sales, the company described the specific development of increased sales through expanded sales of stand-up refill pouches.
  23. FY2017-Q1RestatedAnnual report

    「In terms of earnings, although the company worked to improve production efficiency, strengthen sales of high-value-added products, and reduce costs,」

    The company stated that it continued to improve production efficiency, strengthen sales of high-value-added products, and reduce costs.
  24. FY2016First statedAnnual report

    「Although the company worked to improve production efficiency, strengthen sales of high-value-added products, and reduce costs,」

    Sales of high-value-added products, improved production efficiency, and cost reductions were cited as means of improving profitability.
Moved together

"Foreign Exchange Risk" moved the same way as this thread, in the same document, in 11 of its 24 moves.

11119976★123456
  1. ★This thread
  2. 1Foreign Exchange Risk11×
  3. 2Improving Operating Profit, Profit Margin and ROA11×
  4. 3Strengthening Growth Drivers9×
  5. 4Focus on efficiency9×
  6. 5Guarantee of borrowings by ZACROS MALAYSIA7×
  7. 6Demand Fluctuations in Electrical and Electronics-Related Markets6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zacros's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.